ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives

August 29, 1975

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

Carbone Heads Chairmen’s Group

June 30, 1978

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006